Stocks
Novus Incorporated DelNVUS
HealthcareMedical Devices
A developer of advanced wound care products, this company focuses on regenerative medicine and skin substitutes for chronic and acute wounds. Its portfolio includes FDA-approved products for diabetic foot ulcers and venous leg ulcers, and it has faced financial challenges while seeking to commercialize its technology. Investors track the stock for its potential in the wound care market and its ongoing restructuring efforts.
Congressional Interest in Novus Incorporated Del (NVUS)
1 member of Congress has disclosed 1 trade in Novus Incorporated Del (NVUS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading NVUS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-03-06 | JAMES B. RENACCI | buy | $1K-$15K |